In clinical trials, patients began seeing improvements in sleep apnea symptoms within a few months as they lost weight
Compounded semaglutide is a synthetic analoga modified version that binds to the same cellular receptors but lasts for nearly a week, providing sustained appetite and blood-sugar control
One hypothesis is that chronic GIP receptor agonism desensitizes the GIP receptor, creating an antagonism, which ultimately leads to weight loss
Results differ, though some note significant drops after a few months of therapy compared to placebo
Originally developed and FDA-approved for managing type 2 diabetes, Ozempic belongs to a group of medications known as GLP-1 receptor agonists
Afshin A, Forouzanfar MH, Reitsma MB, et al